EPISODE · May 23, 2022 · 39 MIN
Righting The Gut-Brain Connection With Mahana Therapeutics' Steven Basta
from TD Cowen Insights · host TD Cowen Insights
Recorded on 05/18/22 In this episode, we discuss the connection between the gut and the brain. We know that one's mental state can affect the body, and this is particularly true for those suffering from IBS. While there are many treatments on the market for IBS, they are not always effective and come with potential side effects. But now it is possible to treat IBS digitally. We explore the topic with Steven Basta, CEO of Mahana Therapeutics. Mahana IBS is the first FDA approved prescription digital therapeutic for the treatment of IBS. It uses cognitive behavioral therapy, or CBT, to help people build a healthier brain-gut relationship, decrease symptom severity, and increase overall well-being. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Recorded on 05/18/22 In this episode, we discuss the connection between the gut and the brain. We know that one's mental state can affect the body, and this is particularly true for those suffering from IBS. While there are many treatments on the market for IBS, they are not always effective and come with potential side effects. But now it is possible to treat IBS digitally. We explore the topic with Steven Basta, CEO of Mahana Therapeutics. Mahana IBS is the first FDA approved prescription digital therapeutic for the treatment of IBS. It uses cognitive behavioral therapy, or CBT, to help people build a healthier brain-gut relationship, decrease symptom severity, and increase overall well-being. For Disclosures, click here bit.ly/3cPHkNW
NOW PLAYING
Righting The Gut-Brain Connection With Mahana Therapeutics' Steven Basta
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m